Amarin Corporation plc (AMRN)
Free
No email, no account, no signup.
Pulling latest news for Amarin Corporation plc…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Cardiovascular pharmaceuticals
Market Cap
$312M
We're already tracking Amarin Corporation plc — here are the latest events we've registered
Recent News
- On May 1, 2026, Amarin reported its first-quarter financial results, highlighting a narrowed operating loss and positive operating cash flow for the second consecutive quarter. The company ended the period with $308 million in cash and reiterated its expectation to be cash-flow positive for the full year 2026. Additionally, Amarin continues to expand its international presence, recently securing reimbursement for VAZKEPA in several European markets.
Want to know how this news affects Amarin Corporation plc? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Amarin Corporation plc will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.